CD4 and pneumonitis: Furthermore, a notable increase in ICOS+CD4+ T cells in the periphery of aged mice and patients with pneumonitis, but not young mice or irAE-free patients following anti–PD-(L)1 therapy, suggest their predictive value for later incidence of lung toxicity.